Dupilumab Prescriptions for Pediatric EoE Burdened by Prior Authorizations, Delayed Initiation
October 5th 2023An institution's review of prescriptions in the first year since dupilumab's historic FDA approval for eosinopihlic esophagitis shows patients waited a mean 46 days to initiate the biologic therapy.
Read More
Relentless: The Concurrent Alcohol Abuse, Liver Disease Epidemics in the US
October 3rd 2023The COVID-19 pandemic skyrocketed already high rates of alcohol consumption and related liver disease to unprecedented levels. Addiction specialists and hepatologists are still looking for the best path out.
Read More